FIELD: medicine.
SUBSTANCE: invention represents a therapeutic agent containing hydrocortisone acetate, lidocaine hydrochloride and purified water differing by the fact that an active ingredient is thrombolysine, and an ointment base is anhydrous lanolin and purified medical Vaseline; the ingredients of the agent are found in a certain ratio.
EFFECT: enhanced and more effective outward application of the therapeutic agent in inflammatory process with skin repair by increasing permeability and accelerating liquid flow and passage of the active ingredients through interstitial spaces deep into tissues and prolonged local therapeutic action.
| Title | Year | Author | Number |
|---|---|---|---|
| MEDICAL OINTMENT | 2010 |
|
RU2442565C1 |
| OINTMENT FOR TREATING BITTEN WOUNDS | 2011 |
|
RU2473329C2 |
| TOPICAL PREPARATION FOR CONTAMINATED WOUND HEALING | 2012 |
|
RU2512824C2 |
| COMPOSITION AND METHOD FOR PREPARING OPHTHALMIC HYDROCORTISONE OINTMENT | 2003 |
|
RU2282436C2 |
| AGENT FOR TREATMENT OF DERMATOLOGICAL DISEASES | 2001 |
|
RU2197247C2 |
| AGENT FOR WOUNDS, BURNS AND INFECTIOUS INFLAMMATORY DISEASES OF SKIN, APPENDAGES AND MUCOUS MEMBRANES | 2010 |
|
RU2452475C2 |
| COMPOSITION AND METHOD FOR PREPARING CIPROFLOXACIN OPHTHALMIC OINTMENT | 2006 |
|
RU2317810C1 |
| AGENT FOR EXTERNAL USE WITH ANTIVIRAL ACTION | 2021 |
|
RU2819719C2 |
| EXTERNAL AND LOCAL PHARMACEUTICAL STEPHAGLABRIN PREPARATION | 2007 |
|
RU2364399C1 |
| ANTI-INFLAMMATORY OINTMENT FOR ANIMALS | 2019 |
|
RU2730476C1 |
